Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 21Breast 14Thoracic 6Other hematologic neoplasm 6Lymphoid 5Gastrointestinal 5Tumor-Agnostic 4Sarcoma 2Plasma cell 2Other solid neoplasm 2Head & Neck 2Genitourinary 2Myeloid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Cognitive/Functional Effects 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Mental Status and Dementia Tests × Other solid neoplasm × Clear all
NCT00477958 2026-03-27

Assessment Tool for Older Patients With Cancer

City of Hope Medical Center

Phase NA Active not recruiting
1,062 enrolled
Other solid neoplasm

Cognitive/Functional Effects

NCT01019187 2020-04-09

Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
226 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡